Format

Send to

Choose Destination
Health Technol Assess. 2019 Mar;23(10):1-242. doi: 10.3310/hta23100.

Goal-oriented cognitive rehabilitation for early-stage Alzheimer's and related dementias: the GREAT RCT.

Author information

1
Centre for Research in Ageing and Cognitive Health, University of Exeter, Exeter, UK.
2
School of Dementia Studies, University of Bradford, Bradford, UK.
3
Research Institute for the Care of Older People (RICE), Bath, UK.
4
Division of Population Medicine, University Hospital Llandough, Cardiff University, Cardiff, UK.
5
Department of Neuroscience and Experimental Psychology, University of Manchester, Manchester, UK.
6
Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, St Thomas' Hospital, King's College London, London, UK.
7
Centre of the Health of the Elderly, Northumberland, Tyne and Wear NHS Foundation Trust, Newcastle upon Tyne, UK.
8
Kent and Medway NHS and Social Care Partnership Trust, St Martin's Hospital, Canterbury, UK.
9
Dementia Pal Ltd, Southampton, UK.
10
North Wales Organisation for Randomised Trials in Health, Bangor University, Bangor, UK.
11
Personal Social Services Research Unit, London School of Economics and Political Science, London, UK.
12
Institute of Health Research, University of Exeter Medical School, Exeter, UK.
13
Whitaker Research Ltd, Bangor, UK.
14
Dementia Services Development Centre, Bangor University, Bangor, UK.

Abstract

BACKGROUND:

Cognitive rehabilitation (CR) is an individualised, person-centred intervention for people with mild to moderate dementia that addresses the impact of cognitive impairment on everyday functioning.

OBJECTIVES:

To determine whether or not CR is a clinically effective and cost-effective intervention for people with mild to moderate Alzheimer's disease or vascular or mixed dementia, and their carers.

DESIGN:

This multicentre randomised controlled trial compared CR with treatment as usual (TAU). Following a baseline assessment and goal-setting to identify areas of everyday functioning that could be improved or better managed, participants were randomised (1 : 1) via secure web access to an independent randomisation centre to receive either TAU or CR and followed up at 3 and 9 months post randomisation.

SETTING:

Community.

PARTICIPANTS:

Participants had an International Classification of Diseases, Tenth Edition, diagnosis of Alzheimer's disease or vascular or mixed dementia, had mild to moderate cognitive impairment (Mini Mental State Examination score of ≥ 18 points), were stable on medication if prescribed, and had a family carer who was willing to contribute. The exclusion criteria were people with a history of brain injury or other neurological disorder and an inability to speak English. To achieve adequate power, we needed 350 people to complete the trial, with 175 people in each trial arm.

INTERVENTION:

Cognitive rehabilitation consisted of 10 therapy sessions over 3 months, followed by four maintenance sessions over 6 months, delivered in participants' homes. The therapists were nine occupational therapists and one nurse.

OUTCOME MEASURES:

The primary outcome was self-reported goal attainment at 3 months. Goal attainment was also assessed at 9 months. Carers provided independent ratings of goal attainment at both time points. The secondary outcomes were participant quality of life, mood, self-efficacy and cognition, and carer stress, health status and quality of life. The assessments at 3 and 9 months were conducted by researchers who were blind to the participants' group allocation.

RESULTS:

A total of 475 participants were randomised (CR arm, n = 239; TAU arm, n = 236), 427 participants (90%) completed the trial and 426 participants were analysed (CR arm, n = 208, TAU arm, n = 218). At 3 months, there were statistically significant large positive effects for participant-rated goal attainment [mean change in the CR arm: 2.57; mean change in the TAU arm: 0.86; Cohen'sd = 0.97, 95% confidence interval (CI) 0.75 to 1.19], corroborated by carer ratings (Cohen'sd = 1.11, 95% CI 0.89 to 1.34). These effects were maintained at 9 months for both the participant ratings (Cohen's d = 0.94, 95% CI 0.71 to 1.17) and the carer ratings (Cohen's d = 0.96, 95% CI 0.73 to 1.20). There were no significant differences in the secondary outcomes. In the cost-utility analyses, there was no evidence of cost-effectiveness in terms of gains in the quality-adjusted life-years (QALYs) of the person with dementia (measured using the DEMentia Quality Of Life questionnaire utility score) or the QALYs of the carer (measured using the EuroQol-5 Dimensions, three-level version) from either cost perspective. In the cost-effectiveness analyses, by reference to the primary outcome of participant-rated goal attainment, CR was cost-effective from both the health and social care perspective and the societal perspective at willingness-to-pay values of £2500 and above for improvement in the goal attainment measure. There was no evidence on the cost-effectiveness of the self-efficacy measure (the Generalized Self-Efficacy Scale) from either cost perspective.

LIMITATIONS:

Possible limitations arose from the non-feasibility of using observational outcome measures, the lack of a general measure of functional ability and the exclusion of people without a carer or with rarer forms of dementia.

CONCLUSIONS:

Cognitive rehabilitation is clinically effective in enabling people with early-stage dementia to improve their everyday functioning in relation to individual goals targeted in the therapy sessions.

FUTURE WORK:

Next steps will focus on the implementation of CR into NHS and social care services and on extending the approach to people with rarer forms of dementia.

TRIAL REGISTRATION:

Current Controlled Trials ISRCTN21027481.

FUNDING:

This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 23, No. 10. See the NIHR Journals Library website for further project information.

plain-language-summary:

Cognitive rehabilitation (CR) is a personalised intervention to help people with early-stage dementia to manage everyday activities. This individualised therapy is conducted in people’s own homes over several sessions. A therapist works with the person and the carer to identify realistic and relevant goals, plan how to tackle these and support people in achieving them. Previous small studies suggested that CR could be beneficial.The Goal-oriented cognitive Rehabilitation in Early-stage Alzheimer’s and related dementias: multicentre single-blind randomised controlled Trial (GREAT) was run in eight centres to find out whether or not CR improves everyday functioning. Participants were in the early stages of having Alzheimer’s disease, vascular dementia or mixed dementia, with a family carer involved. At the first assessment, participants identified areas in which they would like to see improvements, and set goals. Participants and carers rated how well participants were currently doing in relation to these goals and completed questionnaires, for example about mood and quality of life. Participants were then randomly selected to either receive CR or continue with treatment as usual (TAU). CR consisted of 10 weekly sessions with the therapist over 3 months, followed by four sessions over the next 6 months. Participants were reassessed after 3 and 9 months.We included 475 participants, and 427 participants (90%) completed the trial (209 participants in the CR arm and 218 participants in the TAU arm). After 3 months, the ratings by both participants and carers in the CR group showed that participants were doing significantly better in relation to their goals, and this was maintained 6 months later. Ratings for the TAU-arm participants did not improve significantly. There were no other differences between the groups. There was a strong economic case for CR.Cognitive rehabilitation is effective in enabling people with early-stage dementia to improve their everyday functioning in relation to individual goals targeted in the therapy sessions. Next steps will focus on the implementation of CR into NHS and social care services.

KEYWORDS:

ACTIVITIES OF DAILY LIVING; ALZHEIMER’S DISEASE; FUNCTIONAL ABILITY; MIXED DEMENTIA; REABLEMENT; RESTORATIVE CARE; TERTIARY PREVENTION; VASCULAR DEMENTIA

PMID:
30879470
PMCID:
PMC6441850
DOI:
10.3310/hta23100
Free full text

Conflict of interest statement

Martin Knapp received funding from Lundbeck Limited (St Albans, UK) in relation to work on depression in younger adults and workplace mental health and from Takeda UK Limited (High Wycombe, UK) for advice on measures of the impact on carers of caring for people with dementia. Zoe Hoare is a member of the Health Services and Delivery Research Associate Board. Bob Woods received a grant from the Welsh Government via Health and Care Research Wales (Cardiff, UK).

Supplemental Content

Full text links

Icon for National Institute for Health Research Journals Library Icon for NCBI Bookshelf
Loading ...
Support Center